Generations Family Health Center: COVID-19 Testing and Vaccine

Generations continues to offer safe curbside COVID-19 testing for anyone with or without symptoms at our Willimantic, Danielson, and Putnam sites.

  • NO APPOINTMENT NEEDED
  • Open to the public
  • Walk-up and drive through testing available
  • A printable registration form is available online in English and Spanish, to save time in line. Visit https://genhealth.org/covid-19-testing
  • No cost to the patient for the test
  • Testing results usually available in 3-5 days 
  • Testing available for all ages 

COVID-19 Testing Hours

Monday-Friday at Generations’ Willimantic, Putnam, and Danielson sites.

9 am-12 noon and 1pm–4 pm

The Danielson and Putnam testing sites are closed during these time periods:

Tuesday AM- DANIELSON CLOSED • Thursday AM- PUTNAM CLOSED

 Note: The schedules above are subject to change depending on weather and other impacting factors.  

 

For more information on testing, go to https://genhealth.org/covid-19-testing

 

Holiday Testing Hours:

  • Generations’ COVID-19 Testing sites will be closed:
  • Thursday, December 24, 2020
  •  Friday, December 25, 2020
  • Thursday, December 31, 2020--Testing Closing at 3pm
  •  Friday, January 1, 2020     
       

 

Vaccine:

We are excited to share that Generations will be receiving the Moderna vaccine the week of December 28th.  We will begin to vaccinate our employees at Generations followed by local healthcare workers who have been enrolled by their employers, following guidance from the Centers for Disease Control and Prevention (CDC) and the state of Connecticut. In the months ahead, we look forward to vaccinating our patients and then our communities and are making preparations to do so based on government recommendations. We will notify our patients and the public when vaccines are available for them.

 

Beginning December 28, find the latest information about the vaccine by heading to our website genhealth.org. There, you will find answers to frequently asked questions, as well as information about the vaccine’s safety and efficacy, patient concerns and the vaccine distribution plan

+